ArticleProceedings of the National Academy of Sciences of the United States of America2026
Constrained evolutionary funnels shape viral immune escape.
Article in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Chaperonin recognition of protein dynamics drives drug resistance.bioRxiv : the preprint server for biology · 2026Article
Corrections and comments
- Update of
Authors and funding
5 authors.
Funding
Abstract
Understanding how viral proteins adapt under immune pressure while preserving viability is crucial for anticipating antibody-resistant variants. We present a probabilistic framework that predicts viral escape trajectories and shows that immune evasion is channeled into a small set of viable "escape funnels" within the vast mutational space. These escape funnels arise from the combined constraints of protein viability and antibody escape, modeled using a generative model trained on homologous sequences and deep mutational scanning data. We derive a mean-field approximation of evolutionary path ensembles, enabling us to quantify both the fitness and entropy of escape routes. Applied to SARS-CoV-2 receptor binding domain, our framework reveals convergent evolution patterns, predicts mutation sites in variants of concern, and explains differences in antibody-cocktail effectiveness. In particular, cocktails with decorrelated escape profiles slow viral adaptation by forcing longer, higher-cost escape paths.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.